SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD

Overview

SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CEFMETAZOLE SODIUM; IMIPENEM AND CILASTATIN FOR INJECTION STERILE BULK; MEROPENEM FOR INJECTION STERILE BULK.

API / Drug Master Files

SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CEFMETAZOLE SODIUMActive2013-08-23
• IMIPENEM AND CILASTATIN FOR INJECTION STERILE BULKActive2010-07-09
• MEROPENEM FOR INJECTION STERILE BULKActive2009-11-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.